Skip to content

Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic

JENA Mechanical Assist Circulatory Support Trial-JENAMACS-hemodynamic

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04451798
Acronym
JenaMACS
Enrollment
20
Registered
2020-06-30
Start date
2016-12-01
Completion date
2026-08-01
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiogenic Shock

Keywords

Impella

Brief summary

Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device

Interventions

DEVICEImpella CP microaxial pump

ramp test

Sponsors

University of Leipzig
Lead SponsorOTHER
Jena University Hospital
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 91 Years
Healthy volunteers
No

Inclusion criteria

* Cardiogenic shock following acute MI or acute heart failure with * systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with * signs of left heart failure and pulmonary congestion * and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l

Design outcomes

Primary

MeasureTime frameDescription
Hemodynamic Parameters due to PA catheterisationDay 1Pulmonary capillary Wedge pressure in dependence of Impella pump level
Echocardiographic Parameters of left and right heart functionDay 1LV- size in dependence of Impella pump level

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORSven Möbius-Winkler, MD

Universityhospital Jena

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026